Table 3 Comparison of hepatocellular carcinoma versus cholangiocarcinoma after propensity score matching
Variable | HCC (n = 43) | CC (n = 51) | p value |
|---|---|---|---|
Male | 28 (65.1) | 33 (64.7) | 0.213 |
Age (years) | 59 (35–81) | 60 (35–80) | 0.967 |
Smoking | 13 (30.2) | 8 (15.7) | 0.092 |
Alcohol use | 11 (25.6) | 4 (7.8) | 0.099 |
HBV positive | 21 (48.8) | 26 (51.0) | 0.836 |
HCV positive | 9 (20.9) | 18 (35.3) | 0.125 |
Total bilirubin | 0.85 ± 0.33 | 0.94 ± 0.46 | 0.241 |
Albumin | 4.1 ± 0.4 | 4.2 ± 0.3 | 0.498 |
INR | 1.05 ± 0.06 | 1.05 ± 0.12 | 0.912 |
Cirrhosis | 3 (7.0) | 6 (11.8) | 0.432 |
Child–Pugh class A | 39 (90.7) | 51 (100) | 0.058 |
Edmondson–Steiner Grades, I–II | 5 (11.6) | 12 (23.5) | 0.379 |
Tumor size | 5.7 ± 3.6 | 5.3 ± 2.4 | 0.596 |
Tumor size ≥ 5 cm | 19 (44.4) | 23 (52.3) | 0.450 |
Tumor number (≥ 2) | 1 (2.3) | 2 (4.5) | 0.570 |
AFP (ng/mL) ≥ 200 | 8 (18.6) | 3 (5.9) | 0.061 |
ICG% | 9.2 ± 4.7 | 9.6 ± 5.5 | 0.686 |
Operative margin > 1 cm | 24 (55.8) | 30 (58.8) | 0.749 |
Major hepatectomy | 23 (53.4) | 35 (68.6) | 0.258 |
Microvascular invasion | 9 (20.9) | 8 (15.7) | 0.510 |
Macrovascular invasion | 6 (13.9) | 1 (1.9) | 0.057 |
Lympho nodules metastasis | 2 (4.6) | 8 (15.7) | 0.062 |
Distal metastasis | 0 (0) | 3 (5.9) | 0.106 |
AJCC stage, I–II | 23 (60.4) | 36 (70.5) | 0.163 |
Antiviral therapy | 18 (41.8) | 25 (49.0) | 0.186 |
Recurrence | 16 (37.2) | 6 (11.8) | 0.004 |
Mortality | 13 (30.2) | 27 (52.9) | 0.027 |
Follow up times (months) | 61 (1–98) | 26 (1–85) | < 0.0001 |